Cytokines, Plasma Immune Activation Markers, and Clinically Relevant Surrogate Markers in Human Immunodeficiency Virus Infection
AUTOR(ES)
Fahey, John L.
FONTE
American Society for Microbiology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=95626Documentos Relacionados
- Levels of Cytokines and Immune Activation Markers in Plasma in Human Immunodeficiency Virus Infection: Quality Control Procedures
- Need for an External Proficiency Testing Program for Cytokines, Chemokines, and Plasma Markers of Immune Activation
- Cytokines, neuropeptides, and other factors in cutaneous immune responses.
- Variables That Affect Assays for Plasma Cytokines and Soluble Activation Markers
- Clinically Relevant Interpretation of Genotype and Relationship to Plasma Drug Concentrations for Resistance to Saquinavir-Ritonavir in Human Immunodeficiency Virus Type 1 Protease Inhibitor-Experienced Patients